Telomir Pharmaceuticals Inc
NASDAQ:TELO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Telomir Pharmaceuticals Inc
NASDAQ:TELO
|
US |
|
A
|
Aristocrat Leisure Ltd
XMUN:AC8
|
AU |
|
A
|
Aristocrat Leisure Ltd
F:AC8
|
AU |
|
P
|
Patkol PCL
SET:PK
|
TH |
|
C
|
Chalice Mining Ltd
XMUN:C8U
|
AU |
|
Mogotes Metals Inc
F:OY4
|
CA |
|
Dlocal Ltd.
NASDAQ:DLO
|
UY |
|
K
|
KBR Inc
F:K6B
|
US |
|
D
|
DHT Holdings Inc
F:D8EN
|
BM |
|
ExpreS2ion Biotech Holding AB
STO:EXPRS2
|
SE |
|
S
|
Schneider Electric SE
XMUN:SND
|
FR |
Intrinsic Value
Is TELO undervalued or overvalued?
See the intrinsic value estimate for Telomir Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Telomir Pharmaceuticals Does
Telomir Pharmaceuticals is a drug-development company focused on experimental treatments for aging-related and other chronic diseases. Its main asset is a small-molecule drug candidate called Telomir-1, which the company is developing to affect the biology of telomeres and related cellular processes. At this stage, it is not selling approved medicines to patients; it is building a pipeline of one or more future therapies through laboratory and preclinical work.
- Headquarters
- United States of America US
- IPO date
- Feb 9, 2024
Earnings Waterfall
Telomir Pharmaceuticals Inc
The intrinsic value for Telomir Pharmaceuticals Inc (TELO) under the Base Case is hidden USD.
Compared with the current market price of 1.02 USD, the stock appears hidden.